![](/img/cover-not-exists.png)
Phase I Trial of Recombinant Immunotoxin Anti-Tac(Fv)-PE38 (LMB-2) in Patients With Hematologic Malignancies
Kreitman, Robert J., Wilson, Wyndham H., White, Jeffrey D., Stetler-Stevenson, Maryalice, Jaffe, Elaine S., Giardina, Steven, Waldmann, Thomas A., Pastan, IraVolume:
18
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2000.18.8.1622
Date:
April, 2000
File:
PDF, 431 KB
english, 2000